Key facts
- This page summarizes Rachel E. Sherman's Form 4 filing for GeneDx Holdings Corp. (WGS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 May 2023, 16:15.
Rachel E. Sherman - 02 May 2023 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)
- Reporting relationship
- Director
- Issuer ticker
- WGS
- Reported as of
- 02 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 May 2023, 16:15:48 UTC
- Prior SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eunkyung Lee, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rachel E. Sherman filed Form 4 for GeneDx Holdings Corp. (WGS) on 04 May 2023.
Change
- Previous filing in this sequence was filed on 31 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WGS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +45,454
- Change %
- +354%
- Price
- $0.000000
- Shares after
- 58,290
- Date
- 02 May 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WGS
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -45,454
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 May 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 45,454
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
Footnote F2
The underlying shares shall vest on the earlier of the (a) date of the 2023 annual meeting of the Issuer's stockholders, and (b) first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer on the applicable vesting date.
SEC remarks
For avoidance of doubt, all numbers above are presented before giving effect to the 33:1 reverse stock split the Issuer's stockholders approved on April 14, 2023, which was previously disclosed in the Current Reports on Form 8-K filed by the Issuer on April 17, 2023 and April 28, 2023, and which shall become effective on May 4, 2023.